Resultados: 3

DOACs versus aspirin for secondary prevention of stroke after ESUS: an updated systematic review and meta-analysis of randomized clinical trials

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Embolic stroke of undetermined source (ESUS) is a nonlacunar ischemic stroke with no clear cause, having a 4%-5% annual recurrence rate. The potential benefits of direct oral anticoagulants (DOACs) relative to aspirin in patients with ESUS remain unclear. OBJECTIVE: We aimed to perform a syst...

Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial

Eur Heart J Open; 4 (5), 2024
AIMS: This study aimed to compare the effects of the combination of rivaroxaban and aspirin with aspirin alone on health-related quality of life in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial. METHODS and results: Health-related quality of life assessed using t...

Anticoagulantes na prática cirúrgica dermatológica

INTRODUÇÃO: Nas últimas décadas, o uso de anticoagulantes vem se tornando mais frequente na população e em faixas etárias mais jovens.OBJETIVO: O objetivo desse artigo é abordar o risco das medicações anticoagulantes mais utilizadas em cirurgia dermatológica.MÉTODOS: Foi realizada revisão da...